- Report
- August 2025
- 184 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2461EUR$2,789USD£2,128GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 190 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 180 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- May 2025
- 200 Pages
Global
From €2197EUR$2,490USD£1,900GBP
- Report
- August 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 190 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2647EUR$3,000USD£2,289GBP
- Report
- September 2025
- 362 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 196 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 381 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- June 2025
- 400 Pages
Global
From €4367EUR$4,949USD£3,777GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2461EUR$2,789USD£2,128GBP
- Report
- September 2024
- 117 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- June 2025
- 89 Pages
North America
From €3044EUR$3,450USD£2,633GBP

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors.
Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more